Prestige Consumer Healthcare (PBH) EBIT Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) EBIT Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.83% |
| Sep 30, 2025 | -1.90% |
| Jun 30, 2025 | -6.22% |
| Mar 31, 2025 | 4.53% |
| Dec 31, 2024 | 3.65% |
| Sep 30, 2024 | 2.40% |
| Jun 30, 2024 | -7.61% |
| Mar 31, 2024 | 5.01% |
| Dec 31, 2023 | 5.74% |
| Sep 30, 2023 | 6.58% |
| Jun 30, 2023 | 2.07% |
| Mar 31, 2023 | -79.69% |
| Dec 31, 2022 | 4.50% |
| Sep 30, 2022 | 6.76% |
| Jun 30, 2022 | 6.77% |
| Mar 31, 2022 | 35.80% |
| Dec 31, 2021 | 2.13% |
| Sep 30, 2021 | 3.47% |
| Jun 30, 2021 | 8.01% |
| Mar 31, 2021 | 71.81% |